سعر سيدونيز 1,500,000 وحدة دولية 2026

Sedonase is an Egyptian streptokinase 1,500,000 IU vial for intravenous infusion by Sedico, a fibrinolytic (thrombolytic) agent.

• Treatment of acute myocardial infarction within 24 hours of the onset of symptoms.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Intravascular dissolution of thrombi and emboli in extensive deep vein thrombosis, pulmonary embolism, acute or subacute peripheral arterial occlusion and central retinal venous or arterial thrombosis.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

• Bleeding (from puncture sites to serious haemorrhage), allergic and anaphylactic reactions, fever and chills, hypotension, arrhythmias and low back pain.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Conditions with existing or very recent haemorrhage or high bleeding risk, e.g. active internal bleeding, recent cerebrovascular accident, intracranial or intraspinal surgery, intracranial neoplasm, severe uncontrolled hypertension and uncontrollable clotting disorders.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Previous severe allergic reaction to streptokinase; streptokinase therapy within the previous 5 days to 12 months or recent streptococcal infection (high antibody titres); pregnancy.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Anti-streptokinase antibodies rise after treatment and persist for months; repeated therapy within 12 months should only be used with great caution.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Anticoagulants and antiplatelet drugs (e.g. heparin, coumarins, aspirin, dipyridamole, NSAIDs)Increase the risk of haemorrhage; coagulation status should be checked before starting streptokinase.Health Products Regulatory Authority (HPRA), Ireland

• Contraindicated in pregnancy (Irish SmPC); bleeding and anaphylactic reactions could cause abortion or fetal death, especially in the first 18 weeks; use only when no safer alternative exists and the disease carries high maternal risk.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Streptokinase: Forms a complex with plasminogen that converts plasminogen to plasmin, which lyses fibrin clots.